AI Visibility Scorecard
LINZESS (linaclotide) for IBS
linzess.com · Healthcare
Somewhat visible. AI bots can read LINZESS (linaclotide) for IBS, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 7 times
Meta AI · Claude · Apple Intelligence
#188,896 of 923,557 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 5.4/10
15
Muse Index Score
iAI agent readiness
Basic · 15/100
0
AI Adoption
iNone detected · 0/100
About LINZESS (linaclotide) for IBS
from our crawl and measurement
"LINZESS is a prescription medication for adults with Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC)." That is how LINZESS (linaclotide) for IBS introduces itself. To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.4 out of 10, readable in places and missing in others.
Our crawl found structured data on the page (MedicalIndication, WebSite), a sitemap and a readable heading structure. It is missing an llms.txt file.
AI crawlers have visited 3 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Good
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.4/10, LINZESS (linaclotide) for IBS has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for LINZESS (linaclotide) for IBS
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for LINZESS (linaclotide) for IBS.
Source & Attribution
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/linzess
Cite this score: Engagemii (2026). "AEO Score for LINZESS (linaclotide) for IBS." Retrieved from https://engagemii.com/aeo/brands/linzess
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform